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ScienceDirectAdvanced electron microscopy techniques have been used to
solve many viral capsid structures. The resulting detailed
structural knowledge contributes to understanding of the
mechanisms of self-assembly, maturation pathways and
virion–host cell interactions. It also acts as inspiration for
design and production of capsid-like artificial protein cages.
Both natural and artificial cages have potential uses in
medicine including as vaccines and in drug delivery. For
vaccines, virus-like particles formed only from outer virion
shells, lacking genetic material, offer the simplest basis for
development, while encapsulation of target molecules inside
protein cages is potentially more challenging. Here we review
advances in cryo-electron microscopy with particular
reference to viral capsid structures. We then consider why
knowledge of these structures is useful, giving examples of
their utilization as encapsulation and vaccine agents. Finally
we look at the importance of structural techniques including
cryo-EM in the rapidly progressing field of designed protein
cages.
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Introduction
In nature, spherical protein cages fulfill a number of
important roles. Perhaps the most well known cages
are the virus capsids, macromolecular machines which
act as protective containers and delivery vehicles for viral
genetic material [1]. Capsid proteins are the main con-
stituents of the outer shell of viruses (which may alsoCurrent Opinion in Structural Biology 2017, 43:148–155 include membrane components) forming the interface
between viruses and host cells and playing a vital role in
cell invasion. Therefore the study of virus protein cages,
in particular their structures, is of importance for under-
standing pathogenicity and, possibly, for producing ther-
apeutics that inhibit capsid–host interactions to limit virus
entry. Cryo-electron microscopy (cryo-EM) has proved a
vital tool for understanding capsid structures and con-
tinues to advance in terms of speed, capability and
achievable resolution.
Virus cages also have applications apart from their natural
role: Non-infectious particles can be constructed from
viral structural proteins produced using recombinant
technology to yield virus-like particles (VLPs). These
can self-assemble to produce an exact reproduction of a
viral capsid, devoid of genetic material. The outer surface
of such VLPs can be modified either chemically or
genetically to produce vaccines with a large number of
attachment points to which antigens can be connected,
resulting in high immunogenicity. VLPs have been uti-
lized as vaccines both clinically and experimentally [2,3].
Clinically, HEPTAVAX-B (Merck) was the first commer-
cial vaccine developed using VLPs, and the HPV vaccines
Gardasil1 (Merck and Co., Inc.) and Cervarix1 (GlaxoS-
mithKline) have also been launched. VLP cavities can
also be filled and their natural cell penetrating abilities
taken advantage of in order to deliver cargoes. These may
be genetic (gene therapy [4]) or a host of other substances
including drugs, inorganic materials and even functional
proteins [5].
Finally, synthetic biology approaches are increasingly
allowing us to design bespoke protein cages with desired
properties. This represents the frontier of protein cage
research and offers the prospect of a widening of protein
cage capabilities to include new structures with novel
medical applications. A visual summary is shown in
Figure 1.
Advanced cryo-EM for understanding protein
cage structures
Producing symmetrical and spherical structures from
multiple copies of the same protein is an efficient way
to build a container to protect a genome if the genome
itself is small and so can only encode a limited number of
proteins. Many viruses adopt this idea to build a protein
cage (known as a capsid) with the most common capsidwww.sciencedirect.com
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Production, modification and application of natural and artificial protein
cages. Virus-like particles (VLPs) are generated by removing genetic
material, making them non-infectious. However, they retain the
antigenicity of the native virus, meaning that they remain useful as
vaccines. Non-antigenic VLPs can be converted to useful vaccines by
attachment of antigens from other viruses. Artificial protein cages can
be designed from component proteins in silico and then assembled in
vitro. Both VLPs and artificial cages can be used to encapsulate useful
molecules (e.g., therapeutics) and can be surface-modified with
antigens, cell-targeting/penetrating groups or with groups that may
provide a detectable signal depending on interaction with the
environment. Such assembled VLPs and cages have applications as
vaccines, drug delivery systems and bio-sensors, amongst others.geometry being icosahedral. These icosahedral virions
have been used as a target of single-particle reconstruc-
tion since the early days of the technique because the
produced images are easy to process. In fact, the first near-
atomic resolution structure exploiting single-particle
reconstruction was achieved using icosahedral viruses
[6–9]. The first de novo model building was also carried
out using an icosahedral virus [6]. The advantages of
using cryo-EM instead of X-ray crystallography is that
a small amount of virus particles is often enough towww.sciencedirect.com achieve 3D structures. Rhinovirus C is a good example
[10,11] where, in spite of a relatively low concentration of
the virions, a 2.8 A˚ resolution structure was obtained by
cryo-EM and single-particle reconstruction. As a result of
not requiring a potentially time-consuming crystallization
step, timely structural analysis of emerging viruses such as
Zika virus becomes possible [12]. This will allow impor-
tant viruses in terms of pathology to be studied in more
detail. For instance, differences between genogroups can
be obtained, leading to vaccine designs for viruses with
various kinds of serotype.
Whereas the high-resolution structures of icosahedral and
non-enveloped viruses have been successfully pursued,
the next and more formidable challenges are the non-
symmetrical virus particles such as enveloped viruses. For
example, the whole structure of herpes simplex virus type
1 (HSV-1) was elucidated using cryo-electron tomography
(cryo-ET) instead of single-particle reconstruction [13].
HSV is composed of three major components, a glycopro-
tein-containing envelope, a proteinaceous layer between
the capsid and the envelope called the tegument, and a
nucleocapsid. Cryo-ET was essential for understanding
the outline structure of HSV because the components
(excepting the icosahedral nucleocapsid shell [14]) are
non-symmetrical.
Recent advanced cryo-ET has revealed very high resolu-
tion structures of non-symmetrical virus particles such as
enveloped viruses. Among them, a historical event is that
of a subtomogram averaging technique reaching a resolu-
tion of 3.9 A˚, which was reported for the atomic model of
the capsid domain and spacer peptide 1 of Gag polypro-
tein of HIV-1 in the immature state [15] (Figure 2a).
This is notable as most of the structures that had been
obtained by subtomogram averaging up until this point
were at a resolution of around 20 A˚ at best, whereas this
work succeeded in building an atomic model. Here, a
brand-new method to acquire tomographic tilt-series; a
dose-symmetric tilt scheme developed by the authors,
was used. With the development of direct electron detec-
tors and appearance of well-controlled electron micro-
scopes equipped with a stable stage, for example, Titan
KRIOS (FEI), the method of acquiring images has
improved. In fact, the implementation of the direct
electron detector is a major factor in the recent dramatic
increase in near atomic resolution structures accom-
plished using single-particle electron cryomicroscopy
[16]. Before its appearance, charge-coupled device
(CCD) sensors having phosphor screens with fiber-optic
coupling were popular. These type of cameras are more
convenient for the microscopist to check the examined
specimen compared to photographic film. However, since
the detective quantum efficiency (DQE) that represents
the loss of input signal of a detector due to noise or the
signal conversion systems in the detector, is worse than
photographic film at high frequency, they are notCurrent Opinion in Structural Biology 2017, 43:148–155
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(a) The CA-SP1 atomic model (PDB 5L93) is visualised with a 3D map
of CA-SP1 (EMD-4015) using UCSF Chimera [51]. The script file used
for UCSF Chimera was downloaded from EM-Navigator [52] (http://
pdbj.org/emnavi/?&lang=en). Scale bar, 2 nm. (b) HIV-1 capsid model
produced using a computer-assisted hybrid approach. The atomic
model, composed of 186 hexamers and 12 pentamers (PDB-3j3y),
was fitted into a 3D map obtained by cryo-ET (EMD-5639) and is
visualized by UCSF Chimera following the same method as for (a).
Scale bar, 20 nm.particularly suitable for high resolution work. This is
because converting electron signals to photons via a
phosphor scintillator and transmitting the photons to
the CCD sensors thorough fiber optics results in blurring,
especially in the scintillator. On the other hand, direct
electron detectors, as the name suggests, can detect
incident electrons directly without conversion to light,
leading to higher DQEs in either high or low frequency
regions compared to CCD cameras and photographic film.
In addition, high-speed readout enables us to correct the
beam-induced motion that is a phenomenon notorious for
causing significant blurring of the recorded images. As a
result, direct electron detection is presently the gold
standard detection method for near-atomic resolution
work [17,18].
The retroviral virions like HIV commonly change their
shape largely through their maturation pathway. In imma-
ture virions, a quasi-spherical shell composed of Gag is
formed. However, size and morphology is not uniform.
Therefore, cryo-ET and the subtomogram averaging
technique is essential to achieve a high-resolution struc-
ture. Even in the mature virion, the capsid core is not
symmetrical but shows a cone-like shape, which is
revealed by cryo-ET [19]. This shape is formed by the
216 hexamers and 12 pentamers composed of six and five
capsid proteins respectively. The non-symmetrical and
cone-like shell shape is related to the locations of the
12 pentamers [20]. Here, a computer-assisted hybrid
approach was used to obtain an atomic model of the
mature capsid shell using X-ray crystallography, NMR,
cryo-ET and molecular dynamics [21] (Figure 2b). This
integrative modeling approach certainly will becomeCurrent Opinion in Structural Biology 2017, 43:148–155 mainstream thanks to the need to acquire more compli-
cated and non-symmetrical capsid structures and the
increasing sophistication and resolution of the techniques
allows us to progressively modify and exploit VLPs, in
particular in the medical field.
Encapsulation and VLP vaccines: exploiting
protein cages in medicine
For medical applications VLPs are attractive as they are
devoid of any kind of nucleic material, and normally are
non-infectious. They can be derived either from viral
sources or synthetically from non-viral cage forming sys-
tems by heterologous expression [22]. When free of the
natural nucleic acid contents, the VLP cage interior
provides an appealing compartment for non-native cargo
encapsulation (Figure 3a). VLPs gained attention because
of their large cargo loading abilities, biocompatibility, in-
vivo targeting and stability [22,23,24] and they are often
able to withstand harsh conditions required for chemical
modification which can be carried out both internally and
externally. The most common modification technique
employs genetic engineering, which is highly effective
for insertion, replacement or deletion of residues, allow-
ing systematic addition of functional groups. One of the
best known examples is mutation to cysteine, which can
be used for disulfide linkages, association with metal, and
bio-conjugation with thiol-selective moieties [25]. Inser-
tion of unnatural amino acids is also possible using this
technique [26].
At present a number of VLP-based drugs are in clinical
trials: T-VEC manufactured by Amgen was recently
approved for oncotherapy against melanoma [27]. Other
promising roles for VLPs as cargo carriers include in
tissue/cell specific delivery of contrast and imaging
agents, mainly in the field of magnetic resonance imaging
(MRI), and positron emission tomography (PET) [28].
VLPs also have great potential as vaccines: Traditional
vaccines have been used against a range of diseases, often
highly successfully with notable examples including
diphtheria, polio and mumps. However, there have been
failures and challenges such as HIV, influenza, Ebola and
some cancers. One of the major problems is to elicit
robust and persistent immune responses, and VLPs are
a promising platform to achieve this as they are capable of
multivalent antigen presentation. For this, the three-
dimensional structure must be known in some detail in
order to decide where the antigens can/should be
attached. One example of successful structure-based
design is Qb VLP carrying a peptide based on CCR5
(a cytosolic self-replicating protein functioning as a co-
receptor for replication and pathogenesis of HIV;
Figure 3b) which boosted adaptive immunity in rhesus
monkeys [29].
Cryo-EM along with X-ray crystallography, has contrib-
uted to this field, by providing fine structural details ofwww.sciencedirect.com
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(a) Example of an icosahedral virus protein cage. The crystal structure of cowpea mosaic virus, widely exploited in bionano science, is shown (
PDB-5fmo [53]). The structure is shown in cartoon format with each copy of the constituent large and small proteins shown in green and cyan
respectively. The exterior of the VLP is shown on the left and revealing the interior cavity on the right. The particle is approximately 28 nm in
diameter. (b) Preparation and conjugation strategy of two CCR5 (a cytosolic self-replicating protein functioning as a co-receptor for replication and
pathogenesis of HIV) vaccine constructs with Qb virus. A linear peptide representing the N terminus (EC1) and a cyclic peptide representing the
undecapeptidyl arch of the second extracellular loop (ECL2) of macaque CCR5 (top), representing two different regions that interact with HIV
gp120 during infection, were synthesized and then conjugated at high density to Qb bacteriophage using the bifunctional cross-linker SMPH to
obtain Qb.EC1 and Qb. ECL2 particles, respectively (bottom). Adapted by permission from reference [36], copyright American Society of
Microbiology, 2014.VLP-based vaccines. The structure of the papillomavirus
VLP, which constitutes the HPV vaccine, has been solved
using cryo-EM to 3.6 A˚ resolution [30,31]. In a separate
study, cryo-EM structures determined from a VLP based
on enterovirus 71 (EV71) and coxsackievirus A16 (respon-
sible for hand, foot, and mouth disease) at 5 A˚ resolution
provided a structural basis for the development of an
improved vaccine candidate [32]. Recently a cryo-EM
structure of chikungunya virus-antibody complex has also
been determined to 5.3 A˚ resolution, which helped in
determining the details of how the antibody neutralizes
the virus [33]. Vaccines against two other important
viruses use recombinant VLPs: hepatitis B virus and
hepatitis E virus. Interestingly, in both these cases,
cryo-EM has been used for the acquisition of high-reso-
lution structural data, allowing progress in understanding
structure–function relationships and demonstrating a
major role for the technique in development of therapeu-
tics [34]. It is also proving highly useful in the new field of
artificial protein cage production.www.sciencedirect.com Artificial protein cages and their potential
therapeutic uses
Artificial virus-like cages are currently under investigation
using a wide variety of building block materials [35].
Synthetic biology approaches allow us to design and
produce artificial protein cages, permitting the production
of structures with bespoke properties free from evolu-
tionary constraints. Cages produced in this way could
have a number of potential uses including as drug deliv-
ery systems or artificial vaccines and may be desirable
because their structural features can be more precisely
controlled. In recent years advances in computational and
experimental techniques have resulted in a number of
artificial cage proteins being designed, produced and
investigated structurally [36,37,38,39,40,41,42]. How-
ever, there are still constraints: The large size of artificial
cages means that, due to limitations inherent in protein
expression and folding, they, like their natural counter-
parts, must be constructed of large numbers of identical,
individual protein subunits arranged with high symmetry.Current Opinion in Structural Biology 2017, 43:148–155
152 Macromolecular assembliesThis can present challenges in their design. The
approaches used to overcome these challenges have
been reviewed in depth elsewhere [37,41,43] and are
covered briefly here.
The role of cryo-EM in artificial protein cage production
compared to naturally occurring cages is focused more onFigure 4
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Current Opinion in Structural Biology 2017, 43:148–155 confirming the success of the design and highlighting any
unexpected deviations from the predicted structure. This
is important as the designs are made at the atomic scale
with specific amino acid side chain interactions making
up the protein–protein interfaces. While other biophysi-
cal techniques such as dynamic light scattering may be
able to give an approximate size of the produced cage(d)
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s example a protein with threefold rotational symmetry (green) is fused
]. The proteins assemble into a tetrahedral cage as shown
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e presence of a cavity. From reference [39]. Reprinted with permission
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A docked structure is produced. v) Close up of a protein–protein
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nds (dotted lines). From reference [37]. Reprinted with permission
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matches the design.
Typically, artificial cage proteins are made using one of
two methods, one is a ‘symmetry engineering’ approach
that takes advantage of the fact that the number of
protein structures now known is huge (as of August
2016 the pdb database (www.rcsb.org [44]) consists of
over 120 000 entries). Utilizing this structural repository,
protein monomers which are known to assemble with
particular symmetries can be fused together in silico to
provide hybrid molecules. Satisfying the symmetries of
the individual fused monomers results in formation of
geometrically regular cage structures (Figure 4a). For
example, a protein trimer (providing threefold rotational
symmetry) and a second protein, a dimer (providing
twofold rotational symmetry) can be fused together to
produce a tetrahedral cage [40] with four trimers form-
ing the four vertices of a tetrahedron and the dimers
forming the six edges (Figure 4a).
Another approach is to carefully design the interfaces
between proteins such that new interactions (e.g., hydro-
phobic packing, hydrogen bonds) are introduced to
encourage self-assembly in desired conformations
(Figure 4b). This is a computationally intense approach
and software such as Rosetta has proved useful in provid-
ing advanced modeling of the crucial protein–protein
interfaces between the protein subunits. This approach
can result in quite stable assemblies, with the 60-subunit
icosahedral cage structure recently reported by Hsia
et al. remaining stable up to 80C [42]. Protein cages
made from copies of two different proteins have even
proved possible to design (Figure 4c). Most recently the
interface design approach has led to spectacular success
with Bale et al. reporting the production and structure of
several different protein cages, each made from two
different proteins and spanning a range of sizes and
masses (up to almost 3 MDa) [45]. In many of these
examples cryo-EM was used to confirm the structure of
the produced cages.
Still other novel approaches to protein cage construction
remain to be exploited: One of us (Heddle) has developed
an alternative technique using gold nanoparticles to pro-
mote protein cage formation from a homo-11mer ring
protein known as TRAP (trp RNA-binding attenuator
protein [46,47], Figure 4d). The resulting cage [48,49]
has unusual properties including disassembly in relatively
mild reducing conditions and it may have unusual struc-
ture features which will likely require cryo-EM to fully
resolve.
Design and production of artificial protein cages is still in
its infancy but its potential power is now beginning to be
understood and a large number of applications are envis-
aged [43] including, ultimately, as modular componentswww.sciencedirect.com of more complex protein machines [50] and cryo-EM
analysis will remain a key technique as the field moves
forward.
Conclusions
This review focuses on the design, structure-determina-
tion and (medical) applications of protein cages, both
natural (virus capsids) and artificial. The ability to pro-
duce a hollow, nanoscale ‘ball’ is extremely powerful; the
resulting structure having internal and external faces that
can be addressed independently. They demonstrate the
desirable feature of having an enclosed space separated
from the surrounding environment that can be used to
transport/react cargoes. Building such protein cages
requires structural data and the atomic models of VLPs
or viruses themselves provide useful information for
vaccine design as well as for understanding virus infection
mechanisms. Sometimes structural information is impor-
tant for understanding the difference in effectiveness of
treatments between different genogroups. In such cases,
obtaining atomic resolution structures quickly even in
virus genogroups that are hard to propagate, is important.
Cryo-EM techniques with direct-electron detectors and
sophisticated image processing software are powerful
tools in such cases. Cryo-EM, along with X-ray crystal-
lography, also provides high-resolution structural data of
building block proteins used to construct artificial cages.
In silico design processes use this structural data as a
start point for software-based cage design. The same
structural techniques are then used to validate the
produced structures. Overall, the interplay between
advancing structure-determination techniques, deepen-
ing knowledge of natural protein cage structures and
growing capabilities in artificial cage design are leading
to the production of increasingly useful and sophisticated
protein cages for medical use and beyond.
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